The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities

SK Alyammahi, SM Abdin, DW Alhamad… - Infection, Genetics and …, 2021 - Elsevier
The devastating pandemic of coronavirus disease 2019 (COVID-19) has caused thousands
of deaths and left millions of restless patients suffering from its complications. Increasing …

The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19

Y Gao, I Agache, M Akdis, K Nadeau… - International …, 2022 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic causes an overwhelming
number of hospitalization and deaths with a significant socioeconomic impact. The vast …

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV …

CDL Marques, AM Kakehasi, MM Pinheiro… - RMD open, 2021 - rmdopen.bmj.com
Objectives To evaluate risk factors associated with unfavourable outcomes: emergency care,
hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death in …

Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies

SS Gaikwad, SR Pathare, MA More… - Journal of Controlled …, 2023 - Elsevier
Abstract A Dry Powder Inhaler (DPI) is a technique as well as a device used to inhale
formulation which is in the form of dry powder, and is inhaled through the nose or mouth. It …

COVID-19 and pediatric asthma: clinical and management challenges

JL Boechat, GF Wandalsen, FC Kuschnir… - International journal of …, 2021 - mdpi.com
Asthma is the most frequent chronic condition in childhood and a current concern exists
about asthma in the pediatric population and its risk for severe SARS-CoV-2 infection …

Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis

Y Uruma, T Manabe, Y Fujikura, M Iikura, M Hojo… - PLoS …, 2022 - journals.plos.org
Introduction The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and
asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of …

Associations between COVID-19 outcomes and asthmatic patients with inhaled corticosteroid

SB Yong, SY Gau, CJ Li, CW Tseng, SI Wang… - Frontiers in …, 2023 - frontiersin.org
Background: The impact of inhaled corticosteroid (ICS) in the interaction between asthma,
COVID-19 and COVID-19 associated outcomes remain largely unknown. The objective of …

Therapeutic approaches for chronic obstructive pulmonary disease (COPD) exacerbations

Y Rosenwasser, I Berger, ZG Loewy - Pathogens, 2022 - mdpi.com
Chronic Obstructive Pulmonary Disease (COPD) is a progressive pulmonary disorder
underpinned by poorly reversible airflow resulting from chronic bronchitis or emphysema …

The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19

F Furci, M Caminati, G Senna, S Gangemi - Clinical and Molecular Allergy, 2021 - Springer
Background The observation of patients hospitalized for coronavirus disease (COVID-19)
led us to note a lower prevalence of patients affected by chronic respiratory disease, in …

[PDF][PDF] Постковидный синдром: факторы риска, патогенез, диагностика и лечение пациентов с поражением органов дыхания после COVID-19 (обзор …

ТН Биличенко - Медицинское обозрение, 2022 - rusmedreview.com
РЕЗЮМЕ При COVID-19 среднетяжелого и тяжелого течения развиваются
выраженные воспалительные изменения в легких и других органах, вовлеченных в …